>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance:

  • CUTR -13.6% (guides Q1 revs below consensus, also announces stock offering)

Other news:

  • VXX -5.6% (trading lower with US futures up)
  • APT -4.8% (negatively impacted by lockdown restrictions lifted)
  • LAKE -4.6% (negatively impacted by lockdown restrictions lifted)
  • ZM -4% (work from home play negatively impacted by states reopeninging) 
  • PTON -4% (Trump plan to re-open economy allows for gyms to re-open)
  • NLS -3.7% (Trump plan to re-open economy allows for gyms to re-open)
  • USO -2.3% (crude oil remains under pressure)

Analyst comments:

  • CHWY -4.3% (downgraded to Equal-Weight from Overweight at Morgan Stanley)

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:

  • FUN +13.2% (outlines COVID-19 response; withdraws long-term financial guidance; suspends quarterly distribution), TSG +12.7%, STT +7.1%, UBER +5.7% (withdraws 2020 guidance), SLB +4.1%, WAL +3.8%, ISRG +3.2%, RF +2.5%, MUSA +1.9%, AMWD +1.8% (withdraws fiscal 2020 outlook), IBKC +1.3%

Select index ETFs showing strength:

  • IWM +4.9%, DIA +3.2%, SPY +2.9%, QQQ +1.9%

Other news:

  • CEQP +20.9% (maintains distribution of $0.625 per unit; reduces cap-ex by over $40 mln)
  • MRNA +18% (announces award from US govt to accelerate development of the co's mRNA vaccine candidate),
  • BCRX +16.2% (in sympathy with GILD)
  • HCM +15.5% (receives Fast Track Designations for Surufatinib)
  • GILD +11.8% (early trial data said to suggest that COVID-19 patients are responding to treatment with remdesivir, according to Stat News)
  • BA +9.1% (to resume production of Commercial Airplanes in Puget Sound facilities next week)
  • JWN +7.6% (announces additional measures to strengthen its financial position)
  • JACK +7.2% (names new CEO)
  • MESO +6% (to present positive clinical outcomes using remestemcel-L in patients with inflammatory lung disease at 2020 International Society of Cell and Gene Therapy Meeting)
  • EOLS +5.6% (announces pre-emptive plan to support US aesthetic neurotoxin market in light of the COVID-19 pandemic)
  • TXT +5.5% (awarded $390 mln Navy contract)
  • TGT +1.8% (enters into $900 mln unsecured revolving credit facility)

Analyst comments:

  • LOVE +17.2% (upgraded to Buy from Hold at Stifel)
  • WOW +8.9% (upgraded to Overweight from Sector Weight at KeyBanc Capital Markets)
  • TJX +4.4% (upgraded to Buy from Hold at Jefferies)
  • CAMP +3.4% (upgraded to Buy from Hold at Jefferies)
  • JNPR +2.6% (upgraded to Neutral from Sell at Goldman)

>>> US Early premarket gappers

Early premarket gappers

  • Gapping up:
    • BCRX +25.5%, MESO +21.8%, CEQP +21.1%, HCM +15.5%, MRNA +15.3%, GILD +10.7%, JWN +10%, BA +9.7%, FUN +8.9%, UBER +7.3%, EOLS +5.6%, TXT +5.5%, IWM +5.3%, JACK +4.6%, LULU +4.1%, DIA +3.3%, SPY +3%, ISRG +3%, FB +2.8%, TGT +2.4%, QQQ +2.3%, AMWD +1.8%, AAPL +1%
  • Gapping down:
    • CUTR -14.4%, APT -7.7%, NLS -7.4%, PTON -6.5%, VXX -5.4%, LAKE -4.6%, ZM -3.6%, NFLX -2.2%